Continue with FacebookLooking to list your PhD opportunities? Log in here.
Pharmacology PhD Projects, Programmes & Scholarships
We have 140 Pharmacology PhD Projects, Programmes & Scholarships
PhD saved successfully
Breast cancer treatment and the mechanical properties of fibroblasts
In breast cancer, the amount of extracellular stroma is an indicator of poor prognosis. Read more
Development of novel pyrazolyl-urea compounds as novel anticancer drugs
Introduction. An opportunity to apply for a funded full-time PhD in the Faculty of Health and Applied Sciences at UWE Bristol. . Read more
Development of dietary based novel cancer therapy
Globally, colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and the second in females, with 1.8 million new cases and almost 861,000 deaths in 2018 according to the World Health Organisation. Read more
Combined targeting of PD-L1 and TRAF6 pathways: Implications for Cancer Treatment
The majority of deaths from advanced, difficult-to-treat cancers are a result of metastases. Programmed death 1 ligand (PD-L1), a negative regulator of the immune system, is highly expressed in metastatic cancer cells, and its expression is associated with suppressed anti-tumour immunity. Read more
Differential effects of Cannabidiol: Mechanism(s) of Action and Implications in Cancer
Increasing social acceptance of the ‘non-intoxicating’ cannabidiol (CBD) – one of the major bioactive and non-psychoactive cannabinoids in cannabis sativa – have accelerated its availability and on-/off-label use around the globe. Read more
Utilising small molecule NLRP3 inflammasome inhibitors to treat placental inflammation observed in chronic histiocytic intervillositis, fetal growth restriction and stillbirth
There is increasing evidence that sterile placental inflammation is an underlying cause of placental dysfunction, and contributes to the pathology of chronic histiocytic intervillositis (CHI), villitis of unknown etiology (VUE), fetal growth restriction (FGR) and stillbirth [1-3]. Read more
Novel Therapies targeting Cardiovascular Disease. Synthetic Lipoxin-A4 mimetics: novel therapeutic approaches to target residual inflammatory risk in Atherosclerosis-Associated Diabetes Complications.
Atherosclerosis is a life-long condition essentially due to an inflammatory reaction that drives accumulation of fats and cell debris into the vessel wall, blocking the blood flow. Read more
Understanding the link between SGLT2i’s and skeletal muscle health
Sodium-glucose transport protein 2 inhibitors (SGLT2i) have provided a step change in the way in which we treat and manage those with Type 2 Diabetes Mellitus (T2DM) through their role in the manipulation of glucose reabsorption. Read more
Myotoxic profiles of invertebrate venoms
We are looking to recruit an excellent student for this 4-year fully funded Medical Research Council PhD studentship to investigate the impacts of selective invertebrate venoms on the modulation of skeletal muscle architecture and function. Read more
Last chance to apply
Investigating Pim kinase as a novel anti-thrombotic endothelium targeting strategy
3 year. British Heart Foundation. funded studentship. Platelet-driven thrombosis continues to account for high levels of mortality worldwide. Read more
Clinical impact of environmental dry surface biofilms in Healthcare settings
An exciting opportunity to become part of an internationally recognised research laboratory. Publications in a new field of research. Read more
Last chance to apply
Intestinal G protein-coupled receptors (GPCRs): characterising gut GPCR-signalling with potential to treat colitis.
AIMS. i) to establish the efficacy of first-in-class compounds for gastrointestinal (GI) G protein-coupled receptors (GPCRs) and,. Read more
Last chance to apply
Evaluation of the influence of chemical modifications on antigen presentation and T cell immunity
T-cells, the drivers of adaptive immunity, have great therapeutic potential. However, there are still many unknowns about how they are activated. Read more
SELF-FUNDED MSC BY RESEARCH PROJECT: Advancing novel methods of assessing apathy-related behaviour in rodents
Apathy is a multidimensional syndrome consisting of behavioural, emotional and cognitive components that ultimately lead to a loss of motivation to engage with daily life. Read more
Drug discovery for P2X receptors: molecular basis of ligand-receptor interaction (FOUNTAINS_U23SF)
EP2X receptors are a family of ligand-gated ion channels activated by the neurotransmitter extracellular ATP (Illes et al., 2021). Read more